Your browser doesn't support javascript.
loading
Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants.
de Jong, Jan; Skee, Donna; Murphy, Joe; Sukbuntherng, Juthamas; Hellemans, Peter; Smit, Johan; de Vries, Ronald; Jiao, Juhui James; Snoeys, Jan; Mannaert, Erik.
Afiliação
  • de Jong J; Janssen Research & Development San Diego, California.
  • Skee D; Janssen Research & Development Raritan, New Jersey.
  • Murphy J; Janssen Research & Development Raritan, New Jersey.
  • Sukbuntherng J; Pharmacyclics Inc. Sunnyvale, California.
  • Hellemans P; Janssen Research & Development Beerse, Belgium.
  • Smit J; Janssen Research & Development Beerse, Belgium.
  • de Vries R; Janssen Research & Development Beerse, Belgium.
  • Jiao JJ; Janssen Research & Development Raritan, New Jersey.
  • Snoeys J; Janssen Research & Development Beerse, Belgium.
  • Mannaert E; Janssen Research & Development Beerse, Belgium.
Pharmacol Res Perspect ; 3(4): e00156, 2015 Aug.
Article em En | MEDLINE | ID: mdl-26171235
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmacol Res Perspect Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmacol Res Perspect Ano de publicação: 2015 Tipo de documento: Article